QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-buy-on-generation-bio-maintains-15-price-target

Needham analyst Gil Blum reiterates Generation Bio (NASDAQ:GBIO) with a Buy and maintains $15 price target.

 wedbush-downgrades-generation-bio-to-neutral-maintains-price-target-to-7

Wedbush analyst David Nierengarten downgrades Generation Bio (NASDAQ:GBIO) from Outperform to Neutral and maintains the pric...

 why-sapiens-international-shares-are-trading-higher-by-around-44-here-are-20-stocks-moving-premarket

Shares of Sapiens International Corporation NV (NASDAQ:SPNS) rose sharply in pre-market trading after it announced on Wednesday...

 generation-bio-q2-eps-312-misses-262-estimate-sales-765000k-miss-2139m-estimate

Generation Bio (NASDAQ:GBIO) reported quarterly losses of $(3.12) per share which missed the analyst consensus estimate of $(2....

 generation-bio-has-been-granted-australian-patent-number-2019210034-titled-closed-ended-dna-vectors-obtainable-from-cell-free-synthesis-and-process-for-obtaining-cedna-vectors-for-gene-therapy

https://ipsearch.ipaustralia.gov.au/patents/2019210034

 needham-reiterates-buy-on-generation-bio-maintains-8-price-target

Needham analyst Gil Blum reiterates Generation Bio (NASDAQ:GBIO) with a Buy and maintains $8 price target.

 generation-bio-q1-eps-022-beats-029-estimate-sales-872m-beat-213m-estimate

Generation Bio (NASDAQ:GBIO) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.29...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION